Immune podocytes in the immune microenvironment of lupus nephritis (Review)
- Authors:
- Ruiling Liu
- Xiaoting Wen
- Xinyue Peng
- Miaomiao Zhao
- Liangyu Mi
- Jiamin Lei
- Ke Xu
-
Affiliations: Department of Microbiology and Immunology, Basic Medical College, Shanxi Medical University, Jinzhong, Shanxi 030619, P.R. China, Department of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi 030032, P.R. China, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi 030032, P.R. China, Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Department of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi 030032, P.R. China - Published online on: September 14, 2023 https://doi.org/10.3892/mmr.2023.13091
- Article Number: 204
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Tian J, Zhang D, Yao X, Huang Y and Lu Q: Global epidemiology of systemic lupus erythematosus: A comprehensive systematic analysis and modelling study. Ann Rheum Dis. 82:351–356. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G and Hughes G: Systemic lupus erythematosus. Nat Rev Dis Primers. 2:160392016. View Article : Google Scholar : PubMed/NCBI | |
|
Tektonidou MG, Dasgupta A and Ward MM: Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: A systematic review and bayesian meta-analysis. Arthritis Rheumatol. 68:1432–1441. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Seligman VA, Lum RF, Olson JL, Li H and Criswell LA: Demographic differences in the development of lupus nephritis: A retrospective analysis. Am J Med. 112:726–729. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Aguirre A, Izadi Z, Trupin L, Barbour KE, Greenlund KJ, Katz P, Lanata C, Criswell L, Dall'Era M and Yazdany J: Race, ethnicity, and disparities in the risk of end-organ lupus manifestations following a systemic lupus erythematosus diagnosis in a multiethnic cohort. Arthritis Care Res (Hoboken). 75:34–43. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Tsokos GC, Lo MS, Costa RP and Sullivan KE: New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 12:716–730. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mohan C and Putterman C: Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 11:329–341. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Costenbader KH, Desai A, Alarcón GS, Hiraki LT, Shaykevich T, Brookhart MA, Massarotti E, Lu B, Solomon DH and Winkelmayer WC: Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 63:1681–1688. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Parikh SV and Rovin BH: Current and emerging therapies for lupus nephritis. J Am Soc Nephrol. 27:2929–2939. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Davidson A: What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol. 12:143–153. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kraft SW, Schwartz MM, Korbet SM and Lewis EJ: Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol. 16:175–179. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bomback AS and Markowitz GS: Lupus podocytopathy: A distinct entity. Clin J Am Soc Nephrol. 11:547–548. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wright RD and Beresford MW: Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis. Am J Physiol Renal Physiol. 315:F1683–F1694. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Moustafa FE, Soliman NA, Bakr AM and El Shwaf IM: Assessment of detached podocytes in the Bowman's space as a marker of disease activity in lupus nephritis. Lupus. 23:146–150. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hu W, Chen Y, Wang S, Chen H and Liu Z, Zeng C, Zhang H and Liu Z: Clinical-Morphological features and outcomes of lupus podocytopathy. Clin J Am Soc Nephrol. 11:585–592. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jamaly S, Rakaee M, Abdi R, Tsokos GC and Fenton KA: Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis. Autoimmun Rev. 20:1029802021. View Article : Google Scholar : PubMed/NCBI | |
|
Kang S, Fedoriw Y, Brenneman EK, Truong YK, Kikly K and Vilen BJ: BAFF induces tertiary lymphoid structures and positions T cells within the glomeruli during lupus nephritis. J Immunol. 198:2602–2611. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Schwartz N, Goilav B and Putterman C: The pathogenesis, diagnosis and treatment of lupus nephritis. Curr Opin Rheumatol. 26:502–509. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dieker J, Tel J, Pieterse E, Thielen A, Rother N, Bakker M, Fransen J, Dijkman HB, Berden JH, de Vries JM, et al: Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis. Arthritis Rheumatol. 68:462–472. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Elkon KB: Review: Cell death, nucleic acids, and immunity: Inflammation beyond the grave. Arthritis Rheumatol. 70:805–816. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Salvi V, Gianello V, Busatto S, Bergese P, Andreoli L, D'Oro U, Zingoni A, Tincani A, Sozzani S and Bosisio D: Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7. JCI Insight. 3:e982042018. View Article : Google Scholar : PubMed/NCBI | |
|
Leonard D, Eloranta ML, Hagberg N, Berggren O, Tandre K, Alm G and Rönnblom L: Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes. Ann Rheum Dis. 75:1728–1734. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wen L, Zhang B, Wu X, Liu R, Fan H, Han L, Zhang Z, Ma X, Chu CQ and Shi X: Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus. Front Immunol. 14:10932082023. View Article : Google Scholar : PubMed/NCBI | |
|
Schrezenmeier E, Jayne D and Dörner T: Targeting B cells and plasma cells in glomerular diseases: Translational perspectives. J Am Soc Nephrol. 29:741–758. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Flores-Mendoza G, Sansón SP, Rodríguez-Castro S, Crispín JC and Rosetti F: Mechanisms of tissue injury in lupus nephritis. Trends Mol Med. 24:364–378. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Parikh SV, Almaani S, Brodsky S and Rovin BH: Update on lupus nephritis: Core curriculum 2020. Am J Kidney Dis. 76:265–281. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma M, Vignesh P, Tiewsoh K and Rawat A: Revisiting the complement system in systemic lupus erythematosus. Expert Rev Clin Immunol. 16:397–408. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Pavenstädt H, Kriz W and Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev. 83:253–307. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Garg P: A review of podocyte biology. Am J Nephrol. 47 (Suppl 1):S3–S13. 2018. View Article : Google Scholar | |
|
Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ and Ballestrem C: Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol. 179:1043–1057. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sellin L, Huber TB, Gerke P, Quack I, Pavenstädt H and Walz G: NEPH1 defines a novel family of podocin interacting proteins. FASEB J. 17:115–117. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Garg P, Verma R, Nihalani D, Johnstone DB and Holzman LB: Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol Cell Biol. 27:8698–8712. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G and Benzing T: Molecular basis of the functional podocin-nephrin complex: Mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet. 12:3397–3405. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Dryer SE and Reiser J: TRPC6 channels and their binding partners in podocytes: Role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol. 299:F689–F701. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ha TS: Roles of adaptor proteins in podocyte biology. World J Nephrol. 2:1–10. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Yu F, Song D, Wang SX and Zhao MH: Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: A large cohort study from a single centre. Rheumatology (Oxford). 53:1235–1244. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, et al: TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol. 19:704–713. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Ding F, Zhang X, Li B and Ding J: The expression profile of complement components in podocytes. Int J Mol Sci. 17:4712016. View Article : Google Scholar : PubMed/NCBI | |
|
Gao S, Cui Z and Zhao MH: Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy. J Am Soc Nephrol. 33:1742–1756. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Lv D, Jiang S, Hou Q, Zhang L, Li S, Zhu X, Xu X, Wen J, Zeng C, et al: Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction. Cell Death Dis. 13:2812022. View Article : Google Scholar : PubMed/NCBI | |
|
Pippin JW, Durvasula R, Petermann A, Hiromura K, Couser WG and Shankland SJ: DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest. 111:877–885. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Appay MD, Kazatchkine MD, Levi-Strauss M, Hinglais N and Bariety J: Expression of CR1 (CD35) mRNA in podocytes from adult and fetal human kidneys. Kidney Int. 38:289–293. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Teixeira JE, Costa RS, Lachmann PJ, Würzner R and Barbosa JE: CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients. Clin Exp Immunol. 105:497–503. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Moll S, Miot S, Sadallah S, Gudat F, Mihatsch MJ and Schifferli JA: No complement receptor 1 stumps on podocytes in human glomerulopathies. Kidney Int. 59:160–168. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Bao L, Haas M and Quigg RJ: Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol. 22:285–295. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pickering MC, Ismajli M, Condon MB, McKenna N, Hall AE, Lightstone L, Terence Cook H and Cairns TD: Eculizumab as rescue therapy in severe resistant lupus nephritis. Rheumatology (Oxford). 54:2286–2288. 2015.PubMed/NCBI | |
|
Coppo R, Peruzzi L, Amore A, Martino S, Vergano L, Lastauka I, Schieppati A, Noris M, Tovo PA and Remuzzi G: Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. Pediatr Nephrol. 30:167–172. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Patole PS, Pawar RD, Lech M, Zecher D, Schmidt H, Segerer S, Ellwart A, Henger A, Kretzler M and Anders HJ: Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant. 21:3062–3073. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Devarapu SK and Anders HJ: Toll-like receptors in lupus nephritis. J Biomed Sci. 25:352018. View Article : Google Scholar : PubMed/NCBI | |
|
Kimura J, Ichii O, Miyazono K, Nakamura T, Horino T, Otsuka-Kanazawa S and Kon Y: Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep. 4:72902014. View Article : Google Scholar : PubMed/NCBI | |
|
Marshak-Rothstein A and Rifkin IR: Immunologically active autoantigens: The role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol. 25:419–441. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Anders HJ, Lichtnekert J and Allam R: Interferon-alpha and -beta in kidney inflammation. Kidney Int. 77:848–854. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, Mori M, Inayama Y, Yan K, Kobayashi N and Yokota S: Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol Dial Transplant. 25:2530–2537. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Masum MA, Ichii O, Hosny Ali Elewa Y, Nakamura T, Otani Y, Hosotani M and Kon Y: Overexpression of toll-like receptor 9 correlates with podocyte injury in a murine model of autoimmune membranoproliferative glomerulonephritis. Autoimmunity. 51:386–398. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, Yokouchi M, Shitamura A, Yao J and Kitamura M: Transcriptional suppression of nephrin in podocytes by macrophages: Roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett. 581:421–426. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Niu L, Tang X, Feng R, Yao G, Chen W, Li W, Feng X, Chen H and Sun L: Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype. Nephrol Dial Transplant. 34:597–605. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sung SJ and Fu SM: Interactions among glomerulus infiltrating macrophages and intrinsic cells via cytokines in chronic lupus glomerulonephritis. J Autoimmun. 106:1023312020. View Article : Google Scholar : PubMed/NCBI | |
|
Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D, Chiaffarino F, Abboud HE, Van Damme J, Mantovani A, Remuzzi G, et al: Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol. 138:991–1003. 1991.PubMed/NCBI | |
|
Latz E, Xiao TS and Stutz A: Activation and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fu R, Guo C, Wang S, Huang Y, Jin O, Hu H, Chen J, Xu B, Zhou M, Zhao J, et al: Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis. Arthritis Rheumatol. 69:1636–1646. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Guo C, Fu R, Zhou M, Wang S, Huang Y, Hu H, Zhao J, Gaskin F, Yang N and Fu SM: Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. J Autoimmun. 103:1022862019. View Article : Google Scholar : PubMed/NCBI | |
|
Cai M, Zhou T, Wang X, Shang M, Zhang Y, Luo M, Xu C and Yuan W: DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis. Clin Exp Immunol. 183:317–325. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Haymann JP, Levraud JP, Bouet S, Kappes V, Hagège J, Nguyen G, Xu Y, Rondeau E and Sraer JD: Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol. 11:632–639. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Ichinose K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Tamai M, et al: Lupus Nephritis IgG induction of calcium/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function. Arthritis Rheumatol. 68:944–952. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bhargava R, Lehoux S, Maeda K, Tsokos MG, Krishfield S, Ellezian L, Pollak M, Stillman IE, Cummings RD and Tsokos GC: Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis. JCI Insight. 6:e1477892021. View Article : Google Scholar : PubMed/NCBI | |
|
Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, et al: Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): Prospective study. Rheumatology (Oxford). 60:3388–3397. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mason LJ, Ravirajan CT, Rahman A, Putterman C and Isenberg DA: Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum. 50:866–870. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Renaudineau Y, Deocharan B, Jousse S, Renaudineau E, Putterman C and Youinou P: Anti-alpha-actinin antibodies: A new marker of lupus nephritis. Autoimmun Rev. 6:464–468. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chen A, Lee K, D'Agati VD, Wei C, Fu J, Guan TJ, He JC, Schlondorff D and Agudo J: Bowman's capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells. J Clin Invest. 128:3413–3424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, et al: Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest. 113:1390–1397. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Greka A, Weins A and Mundel P: Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 370:1263–1266. 2014.PubMed/NCBI | |
|
Khullar B, Balyan R, Oswal N, Jain N, Sharma A, Abdin MZ, Bagga A, Bhatnagar S, Wadhwa N, Natchu UCM, et al: Interaction of CD80 with Neph1: A potential mechanism of podocyte injury. Clin Exp Nephrol. 22:508–516. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Coers W, Brouwer E, Vos JT, Chand A, Huitema S, Heeringa P, Kallenberg CG and Weening JJ: Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis. Clin Exp Immunol. 98:279–286. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Goldwich A, Burkard M, Olke M, Daniel C, Amann K, Hugo C, Kurts C, Steinkasserer A and Gessner A: Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol. 24:906–916. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Liu Y, He Y, Rong W, Zhang M, Li L, Liu Z and Zen K: Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease. J Pathol. 252:165–177. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Okamoto A, Fujio K, Tsuno NH, Takahashi K and Yamamoto K: Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int. 82:969–979. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
May CJ, Welsh GI, Chesor M, Lait PJ, Schewitz-Bowers LP, Lee RWJ and Saleem MA: Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation. Am J Physiol Renal Physiol. 317:F913–F921. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng Y, Yang X, Zhang X and An Z: Analysis of expression levels of IL-17 and IL-34 and influencing factors for prognosis in patients with lupus nephritis. Exp Ther Med. 17:2279–2283. 2019.PubMed/NCBI | |
|
Wang N, Gao C, Cui S, Qin Y, Zhang C, Yi P, Di X, Liu S, Li T, Gao G and Zheng Z: Induction therapy downregulates the expression of Th17/Tfh cytokines in patients with active lupus nephritis. Am J Clin Exp Immunol. 7:67–75. 2018.PubMed/NCBI | |
|
Yan J, Li Y, Yang H, Zhang L, Yang B, Wang M and Li Q: Interleukin-17A participates in podocyte injury by inducing IL-1β secretion through ROS-NLRP3 inflammasome-caspase-1 pathway. Scand J Immunol. 87:e126452018. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan DH, Jia Y, Hassan OM, Xu LY and Wu XC: LPS-Treated podocytes polarize naive CD4(+) T Cells into Th17 and treg cells. Biomed Res Int. 2020:85879232020. View Article : Google Scholar : PubMed/NCBI | |
|
Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, Utset TO, Meehan SM, Quigg RJ, et al: In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 186:1849–1860. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tsokos GC: Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 21:605–614. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kolovou K, Laskari K, Roumelioti M, Tektonidou MG, Panayiotidis P, Boletis JN, Marinaki S and Sfikakis PP: B-cell oligoclonal expansions in renal tissue of patients with immune-mediated glomerular disease. Clin Immunol. 217:1084882020. View Article : Google Scholar : PubMed/NCBI | |
|
Senaldi G, Stolina M, Guo J, Faggioni R, McCabe S, Kaufman SA, Van G, Xu W, Fletcher FA, Boone T, et al: Regulatory effects of novel neurotrophin-1/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function. J Immunol. 168:5690–5698. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Schmidt-Ott KM, Yang J, Chen X, Wang H, Paragas N, Mori K, Li JY, Lu B, Costantini F, Schiffer M, et al: Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol. 16:1993–2002. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A and Gauchat JF: Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family. J Immunol Res. 2015:7149642015. View Article : Google Scholar : PubMed/NCBI | |
|
Dos Santos M, Poletti PT, Milhoransa P, Monticielo OA and Veronese FV: Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches. Semin Arthritis Rheum. 46:632–641. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB and Dixon FJ: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 148:1198–1215. 1978. View Article : Google Scholar : PubMed/NCBI | |
|
McGaha TL and Madaio MP: Lupus Nephritis: Animal modeling of a complex disease syndrome pathology. Drug Discov Today Dis Models. 11:13–18. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pawar RD, Castrezana-Lopez L, Allam R, Kulkarni OP, Segerer S, Radomska E, Meyer TN, Schwesinger CM, Akis N, Gröne HJ and Anders HJ: Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier. Immunology. 128 (1 Suppl):e206–e221. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Maibaum MA, Haywood ME, Walport MJ and Morley BJ: Lupus susceptibility loci map within regions of BXSB derived from the SB/Le parental strain. Immunogenetics. 51:370–372. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB and Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 312:1669–1672. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jayne D, Rovin B, Mysler EF, Furie RA, Houssiau FA, Trasieva T, Knagenhjelm J, Schwetje E, Chia YL, Tummala R and Lindholm C: Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis. Ann Rheum Dis. 81:496–506. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Parodis I and Houssiau FA: From sequential to combination and personalised therapy in lupus nephritis: Moving towards a paradigm shift? Ann Rheum Dis. 81:15–19. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Steiger S, Ehreiser L, Anders J and Anders HJ: Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials. Front Immunol. 13:9997042022. View Article : Google Scholar : PubMed/NCBI | |
|
Markowitz GS, Nasr SH, Stokes MB and D'Agati VD: Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 5:607–615. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liao R, Liu Q, Zheng Z, Fan J, Peng W, Kong Q, He H, Yang S, Chen W, Tang X and Yu X: Tacrolimus protects podocytes from injury in lupus nephritis partly by stabilizing the cytoskeleton and inhibiting podocyte apoptosis. PLoS One. 10:e1327242015. View Article : Google Scholar | |
|
Yasuda H, Fukusumi Y, Ivanov V, Zhang Y and Kawachi H: Tacrolimus ameliorates podocyte injury by restoring FK506 binding protein 12 (FKBP12) at actin cytoskeleton. FASEB J. 35:e219832021. View Article : Google Scholar : PubMed/NCBI | |
|
Lee J, Park Y, Jang SG, Hong SM, Song YS, Kim MJ, Baek S, Park SH and Kwok SK: Baricitinib attenuates autoimmune phenotype and podocyte injury in a murine model of systemic lupus erythematosus. Front Immunol. 12:7045262021. View Article : Google Scholar : PubMed/NCBI | |
|
Rice WL, Van Hoek AN, Păunescu TG, Huynh C, Goetze B, Singh B, Scipioni L, Stern LA and Brown D: High resolution helium ion scanning microscopy of the rat kidney. PLoS One. 8:e570512013. View Article : Google Scholar : PubMed/NCBI | |
|
Howie JB and Helyer BJ: The immunology and pathology of NZB mice. Adv Immunol. 9:215–266. 1968. View Article : Google Scholar : PubMed/NCBI | |
|
Hall AM, Ward FJ, Shen CR, Rowe C, Bowie L, Devine A, Urbaniak SJ, Elson CJ and Barker RN: Deletion of the dominant autoantigen in NZB mice with autoimmune hemolytic anemia: Effects on autoantibody and T-helper responses. Blood. 110:4511–4517. 2007. View Article : Google Scholar : PubMed/NCBI |
